Global, Regional, and National Burden of Urolithiasis from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019

References

• Türk C, Petřík A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016;69(3):468–474. doi:10.1016/j.eururo.2015.07.040
   PubMed Web of Science ®Google Scholar
• Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165. doi:10.1016/j.eururo.2012.03.052
   PubMed Web of Science ®Google Scholar
• Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease worldwide. World J Urol. 2017;35(9):1301–1320. doi:10.1007/s00345-017-2008-6
   PubMed Web of Science ®Google Scholar
• Siener R. Nutrition and kidney stone disease. Nutrients. 2021;13(6):1917. doi:10.3390/nu13061917
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca- Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2004;364(9438):937–952.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–683. doi:10.1016/j.jhep.2018.12.001
   PubMed Web of Science ®Google Scholar
• Bai X, Yi M, Dong B, Zheng X, Wu K. The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Exp Hematol Oncol. 2020;9(1):27. doi:10.1186/s40164-020-00181-3
   PubMed Web of Science ®Google Scholar
• Safari S, Kolahi AA, Naghavi M. Global, the regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden Disease study 2019. BMJ Glob Health. 2021;6(11):e004128. doi:10.1136/bmjgh-2020-004128
   PubMed Web of Science ®Google Scholar
• Launer BM, McVary KT, Ricke WA, Lloyd GL. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2021;127(6):722–728. doi:10.1111/bju.15286
   PubMed Web of Science ®Google Scholar
• Murray CJL, Lopez AD. Measuring the Global Burden of Disease. N Engl J Med. 2013;369(5):448–457. doi:10.1056/NEJMra1201534
   PubMed Web of Science ®Google Scholar
• Imamura F, Micha R, Khatibzadeh S, et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health. 2015;3(3):e132–42. doi:10.1016/S2214-109X(14)70381-X
   PubMed Web of Science ®Google Scholar
• Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–2259. doi:10.1681/ASN.2009030276
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833–838. doi:10.1056/NEJM199303253281203
   PubMed Web of Science ®Google Scholar
• van Aswegen CH, Hurter P, van der Merwe CA, et al. The relationship between total urinary testosterone and renal calculi. Urol Res. 1989;17(3):181–183. doi:10.1007/BF00256248
   PubMedGoogle Scholar
• Otunctemur A, Ozbek E, Cakir SS, et al. Urolithiasis is associated with low serum testosterone levels in men. Arch Ital Urol Androl. 2015;87(1):83–86. doi:10.4081/aiua.2015.1.83
   PubMedGoogle Scholar
• Heller HJ, Sakhaee K, Moe OW, Pak CYC. Etiological role of estrogen status in renal stone formation. J Urol. 2002;168(5):1923–1927. doi:10.1097/01.ju.0000033907.21910.be
   PubMed Web of Science ®Google Scholar
• Peerapen P, Thongboonkerd V. Protective cellular mechanism of estrogen against kidney stone formation: a proteomics approach and functional validation. Proteomics. 2019;19(19):e1900095. doi:10.1002/pmic.201900095
   PubMed Web of Science ®Google Scholar
• Nackeeran S, Katz J, Ramasamy R, Marcovich R. Association between sex hormones and kidney stones: analysis of the national health and nutrition examination survey. World J Urol. 2021;39(4):1269–1275. doi:10.1007/s00345-020-03286-w
   PubMed Web of Science ®Google Scholar
• Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298. doi:10.1038/s41574-019-0176-8
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9(9):1645–1652. doi:10.1681/ASN.V991645
   PubMed Web of Science ®Google Scholar
• Trinchieri A, Croppi E, Montanari E. Obesity and urolithiasis: evidence of regional influences. Urolithiasis. 2017;45(3):271–278. doi:10.1007/s00240-016-0908-3
   PubMed Web of Science ®Google Scholar
• Silva GRN, Maciel LC. Epidemiology of urolithiasis consultations in the Paraíba Valley. Rev Colégio Bras Cir. 2016;43:410–415. doi:10.1590/0100-69912016006001
   PubMedGoogle Scholar
• Bartoletti R, Cai T, Mondaini N, et al. Epidemiology and risk factors in urolithiasis. Urol Int. 2007;79(1):3–7. doi:10.1159/000104434
   PubMed Web of Science ®Google Scholar
• Seitz C, Fajkovic H. Epidemiological gender-specific aspects in urolithiasis. World J Urol. 2013;31(5):1087–1092. doi:10.1007/s00345-013-1140-1
   PubMed Web of Science ®Google Scholar
• Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13(Suppl 3):S45–50.
   PubMedGoogle Scholar
• Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017;58(5):299–306. doi:10.4111/icu.2017.58.5.299
   PubMed Web of Science ®Google Scholar
• Gadzhiev N, Prosyannikov M, Malkhasyan V, et al. Urolithiasis prevalence in the Russian Federation: analysis of trends over 15 years. World J Urol. 2021;39(10):3939–3944. doi:10.1007/s00345-021-03729-y
   PubMed Web of Science ®Google Scholar
• Memon A, Anwar K, Orakzai N, et al. Epidemiology of stone disease in Pakistan. In: Talati JJ, Tiselius HG, Albala DM, Ye Z, editors. Urolithiasis: Basic Science and Clinical Practice. Springer; 2012: 21–38. doi:10.1007/978-1-4471-4387-1_3
   Google Scholar
• Basiri A, Shakhssalim N, Khoshdel AR, Ghahestani SM, Basiri H. The demographic profile of urolithiasis in Iran: a nationwide epidemiologic study. Int Urol Nephrol. 2010;42(1):119–126. doi:10.1007/s11255-009-9588-z
   PubMed Web of Science ®Google Scholar
• Free MAHA, Sreedharan J, Muttappallymyalil J, et al. A retrospective study of the seasonal pattern of urolithiasis. Saudi J Kidney Dis Transplant. 2012;23(6):1232. doi:10.4103/1319-2442.103565
   PubMedGoogle Scholar
• Iii AC, Jalloh M, Ndoye M, et al. Surgical management of urolithiasis of the upper tract – current trend of endourology in Africa. Res Rep Urol. 2020;12:225–238. doi:10.2147/RRU.S257669
   PubMed Web of Science ®Google Scholar
• Quarrier S, Li S, Penniston KL, et al. Lower socioeconomic status is associated with adverse urinary markers and surgical complexity in kidney stone patients. Urology. 2020;146:67–71. doi:10.1016/j.urology.2020.09.025
   PubMed Web of Science ®Google Scholar
• Bachour K, Rezaee ME, Swanton AR, et al. Understanding the relationship between health insurance and kidney stones: an examination of NHANES data. Can J Urol. 2020;27(3):10238–10243.
   PubMed Web of Science ®Google Scholar